Daclizumab induction/tacrolimus sparing: A randomized prospective trial in renal transplantation

Clinical Transplantation

Volumn 16, Issue SUPPL. 7, 2002, Pages 30-33

  Light, Jimmy A ^a   Sasaki, Truman M ^a   Ghasemian, Reza ^a   Barhyte, Diana Y ^b   Fowlkes, Deneen L ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

Daclizumab induction; Renal transplantation; Tacrolimus sparing

Indexed keywords

CREATININE; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ARTICLE; CALCIUM SIGNALING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; INFECTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; IMMUNOLOGY;

ANTIBODIES, MONOCLONAL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; TACROLIMUS;

EID: 0036362946     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.16.s7.4.x     Document Type: Article

References (5)

1. JUSKO WJ, THOMSON AW, FUNG J et al. Consensus document: therapeutic monitoring of tacrolimus (FK506). Therapeutic Drug Monitoring 1995: 17: 606.
2. JOHNSON C, AHSAN N, GONWA T et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000: 69: 834.
3. WALDMANN TA, O'SHEA J. The use of antibodies against the IL-2 receptor in transplantation. Curr Opin Immunol 1998: 10: 507.
4. VINCENTI F, KIRKMAN T, BUMGARDNER G et al. Interleukin-2 receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 1998: 338: 161.
5. NASHAN B, MOORE R, AMLOT P et al. Reduction of acute renal allograft rejection by daclizumab: daclizumab double therapy study group. Transplantation 1999: 67: 110.